[Retracted] Downregulation of miR‑30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.

[This retracts the article DOI: 10.3892/ol.2017.

TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.

Cervical cancer (CC) is a common cancer in women and a serious threat to women's lives. TRIM11 has been confirmed as a carcinogen in multiple cancers. Here, we will excavate the detailed mechanism of TRIM11 in CC.

Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.

Accumulating studies have revealed that microRNAs serve crucial roles in cancer development and progression. MicroRNA-30a (miR-30a) has been implicated in various cancer types. However, the role of miR-30a in cervical cancer remains unclear.

Nexrutine inhibits cancer cell growth as a consequence of mitochondrial damage and mitophagy.

Background/aims: Nexrutine is an herbal extract of Phellodendron amurense and has been used as nutrient supplement in China as well as America. Potential protection effect of Nexrutine has been reported.

Methods: To investigate the mechanism of Nexrutine, we used the HeLa, U2OS and HCT116 as a model.

[Reasonable surgical approach for grade III cervical intraepithelial neoplasia].

Objective: To analyze the clinical pathologic characteristics of cervical intraepithelial neoplasia grade III (CINIII ) and to explore optimal surgery for CINIII patients.

Methods: The clinical pathologic characteristics, surgical treatments, prognosis and history of 383 CINIII patients, who hospitalized from August 2005 to December 2010, were reviewed and analyzed. Among the patients, 213 (55.